NCT06881693 Internet-Delivered Cognitive Behaviour Therapy for Depression and Anxiety in Perinatal Parents
| NCT ID | NCT06881693 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Regina |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-02-24 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-02-24 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effectiveness of the Wellbeing Course for New and Expecting Parents (WCNEP), an internet-delivered cognitive behavioral therapy (ICBT) intervention, in reducing symptoms of anxiety and depression in perinatal parents, within a routine care online therapy clinic (the Online Therapy Unit). The study aims to assess treatment uptake, perceptions, feasibility, and effectiveness of the WCNEP in routine care among birthing and non-birthing parents. Over the duration of 8 weeks, participants will review course materials online and respond to questionnaires aimed at assessing changes in various outcomes over time.
Eligibility Criteria
Inclusion Criteria: * Become the guardian of an infant in the last 24 month by birth or adoption/fostering or are expecting the birth of an infant as a birthing parent or partner; * Self-reported difficulty with depression and/or anxiety; * Are aged 18 years or older; or 16 if participant meets criteria to be treated as a mature minor based on Saskatchewan legislation; * Willingness to learn information and skills to self-manage mental health difficulties, consent to course and associated research. Exclusion Criteria: * Current severe medical or psychiatric condition that requires immediate treatment (e.g. current mania or psychosis, actively suicidal or unable to keep themselves safe, medical condition requiring immediate surgery or other invasive treatment); * Living outside of Saskatchewan; * Unable to read and understand English. (All content is provided in English and staff is English speaking; it is cost prohibitive at this time to provide the complete service in languages other than English).
Contact & Investigator
Heather Hadjistavropoulos, PhD
PRINCIPAL INVESTIGATOR
University of Regina
Frequently Asked Questions
Who can join the NCT06881693 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06881693 currently recruiting?
Yes, NCT06881693 is actively recruiting participants. Contact the research team at marcie.nugent@uregina.ca for enrollment information.
Where is the NCT06881693 trial being conducted?
This trial is being conducted at Regina, Canada.
Who is sponsoring the NCT06881693 clinical trial?
NCT06881693 is sponsored by University of Regina. The principal investigator is Heather Hadjistavropoulos, PhD at University of Regina. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.